Armour Thyroid: What to Expect Week by Week in Your First Month

How Armour Thyroid Works and Why the Timeline Matters

Armour Thyroid is a prescription natural desiccated thyroid extract derived from porcine thyroid glands, standardized to contain 38 mcg of levothyroxine (T4) and 9 mcg of liothyronine (T3) per 60 mg (one grain) [1]. Because it contains both hormones, the pharmacokinetics differ meaningfully from levothyroxine monotherapy, and that difference shapes your first-month experience.

T3 Peaks Fast, T4 Builds Slowly

T3 from NDT reaches peak serum concentration within roughly two to four hours of ingestion [2]. T4, by contrast, has a half-life of approximately seven days, so serum T4 and TSH levels take four to six weeks to reach a new steady state after any dose change [3]. This split timeline explains why patients sometimes feel a short-lived energy lift on day one or two while their TSH has barely moved.

Why TSH Is a Lagging Indicator

The pituitary gland down-regulates TSH secretion slowly in response to rising thyroid hormone levels. The American Thyroid Association notes that TSH measurement is the most sensitive test for assessing thyroid status, but only after a new dose has been stable for at least four to six weeks [4]. Checking TSH at week two will almost always show a falsely elevated reading and should not drive early dose escalation.

The Hoang 2013 Crossover Trial

The best published head-to-head data comes from Hoang et al. (J Clin Endocrinol Metab, 2013), a randomized double-blind crossover trial in which 70 patients with hypothyroidism received either NDT or levothyroxine for 16 weeks each [5]. TSH, free T4, and free T3 reached similar target ranges in both arms. Patients on NDT lost an average of 0.9 kg more body weight and reported statistically significant preference for NDT at study end: 48.6% preferred NDT, 18.6% preferred levothyroxine, and 32.9% had no preference [5]. No serious adverse events were attributed to NDT. That preference signal matters clinically because it tells us NDT's dual-hormone profile produces a subjectively different (and for many patients, more satisfying) response than T4 alone, even when TSH endpoints look identical.

Week 1: Day One Through Day Seven

The first week on Armour Thyroid is largely a pharmacological on-ramp. Symptom changes are possible but often subtle.

What Most Patients Notice

The T3 component peaks within hours of the first dose, so some patients report a mild lift in mental clarity or energy on day one or two. This is real but transient. T4 tissue saturation has not yet occurred, so fatigue typically returns by day three or four. A brief afternoon energy dip three to four hours post-dose is common and reflects the T3 curve falling off before T4 exerts its longer-duration effect [2].

Patients switching from levothyroxine rather than starting fresh may notice more pronounced early changes, because they carry existing T4 stores that interact with the newly added T3 dose.

Symptoms That Are Normal in Week 1

Mild palpitations or awareness of heartbeat after the first few doses occur in some patients and usually resolve within 48 to 72 hours as the body adjusts to exogenous T3 [6]. A feeling of mild warmth or slight perspiration in the first few days is also reported. Neither requires stopping the medication unless resting heart rate exceeds 90 to 100 bpm or chest discomfort is present.

What to Track

• Resting heart rate each morning before getting out of bed
• Sleep quality (T3 can be mildly stimulating; some clinicians recommend dosing before noon)
• Energy curve across the day to identify any obvious peak-and-crash pattern

No labs are needed at week one. The FDA-approved prescribing information for Armour Thyroid specifies that routine monitoring should begin at six to eight weeks post-initiation or post-dose change [1].

Week 2: Days Eight Through Fourteen

By week two, T4 levels are climbing toward steady state (roughly 50% of steady-state T4 is achieved by day seven for a once-daily T4 dose) [3]. Patients often notice that the early T3-driven energy lift becomes more sustained and less spiky.

Common Symptom Changes

Brain fog and motivation often show the earliest improvement in week two. Constipation related to hypothyroidism may begin to ease. Cold intolerance, dry skin, and hair loss are slower to respond because they depend on T4-driven genomic effects that require weeks of sustained hormone exposure [7].

Dose Timing Optimization

Some patients do better splitting their daily dose: taking two-thirds in the morning and one-third at midday. This approach reduces the T3 peak-and-trough effect and is supported by the shorter half-life of T3 (approximately 2.5 days) compared with T4 [2]. Discuss any splitting with your prescriber before changing the regimen.

Drug Interaction Window Still Active

Calcium carbonate, ferrous sulfate, proton-pump inhibitors, and soy products all reduce NDT absorption when taken concurrently [8]. The four-hour separation rule remains essential throughout month one and beyond. A 2014 review in Thyroid documented that calcium carbonate reduced T4 absorption by as much as 40% when taken simultaneously [8].

Week 3: Days Fifteen Through Twenty-One

Week three is often when patients first feel something resembling baseline normal function rather than a pharmacological fluctuation.

Why Week 3 Feels Different

T4 is now approaching 75% of steady-state concentration [3]. The combination of rising T4 and the established T3 cycle begins to replicate a more physiologic pattern. Patients on comparable doses of levothyroxine who switched to NDT in the Hoang trial reported improvements in mood and cognition that became apparent in the third and fourth weeks of each treatment period [5].

Symptoms Still Resolving Slowly

Hair loss and dry skin respond to sustained thyroid hormone replacement over months, not weeks [7]. Patients frequently ask why these symptoms persist at week three. The answer is that hair follicles cycle over 60 to 90 day periods, and thyroid hormone must be present at adequate levels throughout that cycle before new growth becomes visible [9]. Reassurance, not dose escalation, is appropriate here.

Monitoring Your Own Titration Signals

The following signals, reviewed with your prescriber, guide whether to hold the current dose at week three or prepare for a week-six titration:

| Signal | Suggests | Action | |---|---|---| | Resting HR consistently above 90 bpm | Over-replacement or T3 sensitivity | Hold; contact prescriber | | Persistent fatigue, brain fog, cold intolerance | Under-replacement | Document; discuss dose increase at week 6 labs | | New-onset insomnia, anxiety, tremor | Excess T3 | Hold morning dose; contact prescriber same day | | Improved energy, stable HR, no palpitations | Dose appropriate | Continue; recheck TSH at week 6 |

Week 4: Days Twenty-Two Through Thirty

The four-week mark is psychologically significant but clinically premature for lab-based dose changes.

What Labs Show at Week 4

TSH may still be above target if you started from severe hypothyroidism, or it may have dropped below target transiently due to T3 exposure, even when T4 has not fully equilibrated [4]. Neither scenario warrants an immediate dose change. The correct response is to repeat labs at week six to eight and evaluate the full panel: TSH, free T4, and free T3.

Free T3 levels in NDT-treated patients often run in the upper half of the reference range (roughly 3.5 to 4.4 pg/mL depending on the assay) while free T4 may sit in the lower half [5]. This pattern is expected given NDT's T4:T3 ratio and does not indicate pathology when the patient is symptom-free and heart rate is normal.

Symptom Checklist at Day 30

By day 30, a well-dosed patient typically reports:

• Energy sufficient for routine daily activities without significant afternoon crashes
• Improved bowel regularity
• Mild improvement in mental clarity and word recall
• Stable resting heart rate below 85 bpm
• Sleep quality similar to or better than pre-treatment baseline

Ongoing fatigue at day 30 with a TSH still above 2.5 mIU/L at week-six labs is a reasonable signal to discuss a 15 mg (quarter-grain) dose increase with your prescriber. The ATA recommends a target TSH of 0.5 to 2.5 mIU/L for most adults with hypothyroidism, though optimal TSH targets may vary by age and cardiovascular status [4].

Armour Thyroid vs. Levothyroxine: What the Evidence Actually Shows

Many patients arrive at Armour Thyroid after years of levothyroxine therapy with persistent symptoms, and the comparative data is worth understanding in detail.

The Hoang Trial in Context

Hoang et al. (2013) remains the most rigorous randomized comparison of NDT versus levothyroxine [5]. The 16-week crossover design controlled for baseline thyroid status and allowed each patient to serve as their own control. Key findings:

• Mean TSH was similar between arms (NDT: 1.66 mIU/L vs. Levothyroxine: 1.71 mIU/L) [5]
• NDT patients had higher free T3 (3.39 vs. 2.84 pg/mL, P<0.001) and lower free T4 [5]
• Neurocognitive testing and metabolic parameters did not differ significantly between groups [5]
• Body weight favored NDT by a mean of 0.9 kg [5]
• Patient preference strongly favored NDT (48.6% vs. 18.6%, P<0.001) [5]

The trial was not powered to detect rare adverse events, and long-term cardiovascular outcomes with NDT remain understudied relative to levothyroxine [10].

What Guidelines Say

The 2014 European Thyroid Association (ETA) guidelines state that levothyroxine monotherapy remains the standard of care for hypothyroidism, but acknowledge that a subset of patients may benefit from combination T4/T3 therapy [11]. The ATA's 2014 hypothyroidism guidelines note that "the available data do not support the routine use of combination therapy" but recognize individualized decision-making for patients who remain symptomatic on levothyroxine with normal TSH [4]. NDT delivers endogenous combination T4/T3 in a fixed ratio and is an FDA-approved prescription preparation that falls within the category of T4/T3 combination therapy.

When Levothyroxine Remains Preferable

Patients with atrial fibrillation, significant coronary artery disease, or osteoporosis need tighter TSH control and a lower risk of T3-driven over-replacement. Levothyroxine's more predictable pharmacokinetics make dose titration safer in those populations [4]. Armour Thyroid's relatively high T3 content per grain (9 mcg) can transiently suppress TSH below 0.1 mIU/L in sensitive patients, which the ATA associates with increased atrial fibrillation risk over time [4].

Dose Titration After Month One

The first-month experience sets the foundation for titration decisions that begin around weeks six to eight.

Standard Titration Protocol

Most prescribers start at 30 mg (half a grain) daily and increase by 15 to 30 mg every four to six weeks until the patient reaches clinical and biochemical euthyroidism [1]. Average replacement doses range from 60 to 120 mg daily for most adults, though some patients require up to 180 mg [1]. Body weight influences dose: a rough estimate is 1.6 mcg of T4-equivalent per kilogram of ideal body weight, applied to the T4 content of NDT [4].

Reading the Six-Week Labs

At the six-week mark, a complete panel should include TSH, free T4, free T3, and a resting heart rate documented in the office. If TSH remains above 2.5 mIU/L with persistent symptoms and heart rate below 80 bpm, a 15 mg increase is generally appropriate. If TSH is below 0.5 mIU/L or heart rate is consistently above 85 bpm at rest, the dose may already be sufficient or slightly excessive and should not be increased [4].

Special Populations

Older adults (age above 65) and those with cardiovascular disease should start at 15 mg daily and titrate more slowly, with a target TSH in the 1.0 to 3.0 mIU/L range to avoid any period of subclinical hyperthyroidism [4]. Pregnant patients require closer monitoring: TSH targets during pregnancy are trimester-specific (first trimester: 0.1 to 2.5 mIU/L; second trimester: 0.2 to 3.0 mIU/L; third trimester: 0.3 to 3.0 mIU/L) per the ATA's 2017 guidelines on thyroid disease in pregnancy [12].

Managing Common Side Effects in Month One

Palpitations

Palpitations in week one are most often benign and relate to the T3 surge. A 2017 review in the Journal of Clinical Endocrinology and Metabolism confirmed that serum T3 levels two to four hours after NDT ingestion often exceed the upper reference limit, returning to normal by hour eight [13]. Taking the dose with a small amount of food (not calcium-containing) can blunt the T3 peak without significantly reducing total absorption.

Insomnia

NDT taken after noon correlates with sleep-onset difficulty in some patients because of T3's mild adrenergic-like stimulating effect [6]. Shifting the entire dose to first thing in the morning, 30 to 60 minutes before eating, addresses this in most cases.

Weight Changes

A small decrease in body weight (consistent with the 0.9 kg signal from Hoang et al.) is expected as metabolic rate normalizes [5]. Significant weight loss exceeding two to three kilograms in the first month is a signal to check TSH and free T3 and consider dose reduction.

Hair Shedding (Telogen Effluvium)

Paradoxically, patients sometimes experience increased hair shedding in the first four to six weeks of thyroid hormone replacement. This reflects the hair follicle cycle resuming after a period of hypothyroid arrest, and it resolves within two to four months in most cases [9]. It does not indicate the medication is causing harm.

When to Contact Your Prescriber Before the Six-Week Check

Contact your prescriber before the scheduled six-week visit if any of the following occur:

• Resting heart rate above 100 bpm on two or more consecutive mornings
• Chest pain, shortness of breath, or irregular heartbeat
• Severe anxiety or tremor that began after starting NDT
• Fever or sweating disproportionate to ambient temperature
• TSH from an outside lab below 0.1 mIU/L

These signals may indicate acute over-replacement and warrant a dose reduction or temporary hold rather than watchful waiting [1].

Practical Checklist for Month One

• Take Armour Thyroid on an empty stomach, 30 to 60 minutes before breakfast
• Separate calcium, iron, or antacid supplements by at least four hours [8]
• Log resting heart rate daily for the first two weeks, then weekly
• Schedule your six-week lab draw before you leave your initiating appointment
• Request TSH, free T4, and free T3 at that six-week draw, not TSH alone
• Store tablets below 25°C in a dry location away from bathroom humidity